Azenta acquires UK Biocentre for GBP 20.5 million

Azenta, Inc.

Azenta, Inc.

AZTA

0.00

Azenta Inc.’s wholly owned subsidiary Azenta UK Ltd has acquired UK Biocentre Limited for total consideration of GBP 20.5 million, net of cash, including up to GBP 1.8 million contingent on milestones. Azenta said the deal expands its sample management, storage and high-throughput processing capabilities in the UK and establishes UK Biocentre as a European operational hub supporting customers across the region.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Azenta Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202603040911PR_NEWS_USPR_____NE01324) on March 04, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.